# BriaCell Therapeutics Corp. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/briacell-therapeutics-corp | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-26T04:48:52.770109+00:00 | | Last reviewed | 2026-10-26T04:48:52.770109+00:00 | ## Identity - Legal name: BriaCell Therapeutics Corp. - Display name: BriaCell Therapeutics Corp. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-26T10:33:30.826918+00:00 | | Completeness | 0.409 | | Record Quality | 0.815 | | Directors | 5 | | Committees | 4 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Martin E. Schmieg: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:5 - Dr. Jane Gross: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (member). claim_id=alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:10 - Dr. Rebecca Taub: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:17 - Dr. Vaughn C. Embro-Pantalony: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Audit (chair); Compensation (member). claim_id=alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:10 - Mr. Jamieson Bondarenko: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Nominating and Governance (chair). claim_id=alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:17 ## Committees - Audit (audit). Chair: Dr. Vaughn C. Embro-Pantalony. Members: Dr. Vaughn C. Embro-Pantalony (chair, current); Dr. Jane Gross (member, current); Martin E. Schmieg (member, current). committee_id=alpha:committee:briacell-therapeutics-corp:audit - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Martin E. Schmieg (member, current). committee_id=alpha:committee:briacell-therapeutics-corp:audit-compensation-chair - Compensation (compensation). Chair: Martin E. Schmieg. Members: Martin E. Schmieg (chair, current); Dr. Vaughn C. Embro-Pantalony (member, current). committee_id=alpha:committee:briacell-therapeutics-corp:compensation - Nominating and Governance (nominating_governance). Chair: Mr. Jamieson Bondarenko. Members: Mr. Jamieson Bondarenko (chair, current); Dr. Rebecca Taub (member, current). committee_id=alpha:committee:briacell-therapeutics-corp:nominating-and-governance ## Executive leadership - Gadi Levin, CA, MBA: Chief Financial Officer and Corporate Secretary [CFO]. Status: current. claim_id=alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:6 - Giuseppe Del Priore, MD, MPH: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:7 - Miguel A. Lopez-Lago, PhD: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:8 - William V. Williams, MD, FRCP: President, Chief Executive Officer, and Director [CEO]. Status: current. claim_id=alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:9 ## Governance events - CFO_CHANGED: Gadi Levin, CA, MBA executive of BriaCell Therapeutics Corp., effective 2025-10-16. Effective: 2025-10-16. Detected: 2026-10-26T04:48:52.770109+00:00. event_id=alpha:event:transition:1hs0ribk424rh - EXECUTIVE_APPOINTED: Giuseppe Del Priore, MD, MPH executive of BriaCell Therapeutics Corp., effective 2025-10-16. Effective: 2025-10-16. Detected: 2026-10-26T04:48:52.770109+00:00. event_id=alpha:event:transition:eeg3pssv3d3i - EXECUTIVE_APPOINTED: Miguel A. Lopez-Lago, PhD executive of BriaCell Therapeutics Corp., effective 2025-10-16. Effective: 2025-10-16. Detected: 2026-10-26T04:48:52.770109+00:00. event_id=alpha:event:transition:1u156qtnrj2op - CEO_CHANGED: William V. Williams, MD, FRCP executive of BriaCell Therapeutics Corp., effective 2025-10-16. Effective: 2025-10-16. Detected: 2026-10-26T04:48:52.770109+00:00. event_id=alpha:event:transition:1cziy1iblc03q - DIRECTOR_APPOINTED: Martin E. Schmieg seat on BriaCell Therapeutics Corp., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T04:48:52.770109+00:00. event_id=alpha:event:transition:5tvrpn1q0j4cx - COMMITTEE_CREATED: Audit; Compensation · Chair committee of BriaCell Therapeutics Corp., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T04:48:52.770109+00:00. event_id=alpha:event:transition:hds9xx1hv72r9 - COMMITTEE_MEMBER_ADDED: Martin E. Schmieg member of Audit; Compensation · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T04:48:52.770109+00:00. event_id=alpha:event:transition:5hhqsp16l2ycr ## Scoped resources - `alpha://company/briacell-therapeutics-corp` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record - `alpha://company/briacell-therapeutics-corp/identity` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=identity - `alpha://company/briacell-therapeutics-corp/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=corporate-structure - `alpha://company/briacell-therapeutics-corp/board` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=board - `alpha://company/briacell-therapeutics-corp/committees` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=committees - `alpha://company/briacell-therapeutics-corp/leadership` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=leadership - `alpha://company/briacell-therapeutics-corp/ownership` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=ownership - `alpha://company/briacell-therapeutics-corp/financials` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=financials - `alpha://company/briacell-therapeutics-corp/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=capital-structure - `alpha://company/briacell-therapeutics-corp/compensation` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=compensation - `alpha://company/briacell-therapeutics-corp/governance` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=governance - `alpha://company/briacell-therapeutics-corp/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=shareholder-governance - `alpha://company/briacell-therapeutics-corp/audit` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=audit - `alpha://company/briacell-therapeutics-corp/legal` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=legal - `alpha://company/briacell-therapeutics-corp/risk` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=risk - `alpha://company/briacell-therapeutics-corp/cyber` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=cyber - `alpha://company/briacell-therapeutics-corp/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=ai-governance - `alpha://company/briacell-therapeutics-corp/agents` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=agents - `alpha://company/briacell-therapeutics-corp/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=ecosystem - `alpha://company/briacell-therapeutics-corp/events` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=events - `alpha://company/briacell-therapeutics-corp/relationships` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=relationships - `alpha://company/briacell-therapeutics-corp/assessments` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=assessments - `alpha://company/briacell-therapeutics-corp/evidence` (contract): https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:11: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:dr-vaughn-c-embro-pantalony","name":"Dr. Vaughn C. Embro-Pantalony"},"source_id":"board_seats"}` - Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:12: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:dr-jane-gross","name":"Dr. Jane Gross"},"source_id":"board_seats"}` - Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:mr-martin-schmieg","name":"Martin E. Schmieg"},"source_id":"board_seats"}` - Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:mr-martin-schmieg","name":"Martin E. Schmieg"},"source_id":"board_seats"}` - Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:dr-vaughn-c-embro-pantalony","name":"Dr. Vaughn C. Embro-Pantalony"},"source_id":"board_seats"}` - Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:mr-jamieson-bondarenko","name":"Mr. Jamieson Bondarenko"},"source_id":"board_seats"}` - Claim alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:dr-rebecca-taub","name":"Dr. Rebecca Taub"},"source_id":"board_seats"}` ## Leadership - Martin E. Schmieg: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:5. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:122edb2683a961e7bb4b9355c2e0cef0a1f73d61080460852d8f6dd3a122642c. - Gadi Levin, CA, MBA: Chief Financial Officer and Corporate Secretary. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:6. Valid from: 2025-10-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0f54f2047e2fb704c660bbcd358a1d2a4a4dd7ca3d16c0423abd577a9d4540f. - Giuseppe Del Priore, MD, MPH: Chief Medical Officer. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:7. Valid from: 2025-10-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:27429acc03a62e58fb0c7fe26f9722737eeda1cf0b1c8a0060f7b2e2c52e788a. - Miguel A. Lopez-Lago, PhD: Chief Scientific Officer. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:8. Valid from: 2025-10-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:66139f3670f4d313f95ce0b550a5f0292cb3513e7f9646bd25026e7b30d026da. - William V. Williams, MD, FRCP: President, Chief Executive Officer, and Director. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:leadership_role:9. Valid from: 2025-10-16. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6104398cd9020884a8ebe06c772e263ecf65b20ac68eb973c945c032c95009d5. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Dr. Vaughn C. Embro-Pantalony; Members Dr. Vaughn C. Embro-Pantalony (Chair); Dr. Jane Gross; Martin E. Schmieg. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. - Compensation: Chair Martin E. Schmieg; Members Martin E. Schmieg (Chair); Dr. Vaughn C. Embro-Pantalony. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. - Nominating and Governance: Chair Mr. Jamieson Bondarenko; Members Mr. Jamieson Bondarenko (Chair); Dr. Rebecca Taub. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - BriaCell Therapeutics Corp.. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0. ## Entity Status - Public listing published. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0. ## Published Fact - US. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0. ## Committee Appointment - Dr. Vaughn C. Embro-Pantalony: chair, Audit. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. - Dr. Jane Gross: member, Audit. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. - Martin E. Schmieg: member, Audit. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. - Martin E. Schmieg: chair, Compensation. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. - Dr. Vaughn C. Embro-Pantalony: member, Compensation. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. - Mr. Jamieson Bondarenko: chair, Nominating and Governance. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. - Dr. Rebecca Taub: member, Nominating and Governance. Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d. ## Security Listing - BCTX (NASDAQ). Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0. - BCTXL (NASDAQ). Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0. - BCTXZ (NASDAQ). Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0. - BCT (TSX). Claim: alpha:claim:company:d12271ff-dda7-4f2e-a9ab-7aa1cd82c790:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:a86d1000f650ec879b562d31bcdd731cad0481dfe44692a263b607130eaf7bf0: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/briacell-therapeutics-corp). - alpha:projection-evidence:document:122edb2683a961e7bb4b9355c2e0cef0a1f73d61080460852d8f6dd3a122642c: [BriaCell Therapeutics Corp. DEF 14A 2026-02-12](https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm). - alpha:projection-evidence:document:f0f54f2047e2fb704c660bbcd358a1d2a4a4dd7ca3d16c0423abd577a9d4540f: [BCTXZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm). - alpha:projection-evidence:document:27429acc03a62e58fb0c7fe26f9722737eeda1cf0b1c8a0060f7b2e2c52e788a: [BCTXL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm). - alpha:projection-evidence:document:66139f3670f4d313f95ce0b550a5f0292cb3513e7f9646bd25026e7b30d026da: [BCTXZ 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm). - alpha:projection-evidence:document:6104398cd9020884a8ebe06c772e263ecf65b20ac68eb973c945c032c95009d5: [BCTXL 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1610820/000149315225018212/form10-k.htm). - alpha:projection-evidence:e752a54258c6b71a31672f4cec388493ded3e2bbe7ba2044e05f63e659c9d79d: [Audit](https://www.sec.gov/Archives/edgar/data/1610820/000149315226006390/formdef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/briacell-therapeutics-corp) - [Public Markdown](https://registry.alpha.ac/companies/briacell-therapeutics-corp.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/briacell-therapeutics-corp?format=jsonld) - MCP resource: `alpha://companies/briacell-therapeutics-corp` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-26T10:33:30.592367+00:00; recorded 2026-10-26T10:33:30.592367+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.